Anticonvulsant effect of celecoxib on pentylenetetrazole-induced convulsion: Modulation by no pathway

Acta Neurobiologiae Experimentalis

Volumn 70, Issue 4, 2010, Pages 390-397

  Zandieh, Ali ^a   Maleki, Farid ^a   Hajimirzabeigi, Alireza ^a   Zandieh, Basira ^a   Khalilzadeh, Omid ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Celecoxib; Cyclooxygenase type 2; L arginine; L NAME; Mice; Nitric oxide; Pentylenetetrazole; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; ARGININE; CELECOXIB; ENZYME INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTETRAZOLE; PYRAZOLE DERIVATIVE; SULFONAMIDE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG INTERACTION; EPILEPSY; MALE; METABOLISM; MOUSE; NONPARAMETRIC TEST;

ANIMALS; ANTICONVULSANTS; ARGININE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; EPILEPSY; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTYLENETETRAZOLE; PYRAZOLES; STATISTICS, NONPARAMETRIC; SULFONAMIDES;

EID: 78951476417     PISSN: 00651400     EISSN: 00651400     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Abramson SB, Attur M, Amin AR, and Clancy R (2001) Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3: 535-541.
2. Akarsu ES, Ozdayi S, Algan E, and Ulupinar F (2006) The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: possible role of cyclooxygenase-2 induction. Epilepsy Res 71: 181-187.
3. Arancio O, Antonova I, Gambaryan S, Lohmann SM, Wood JS, Lawrence DS, and Hawkins RD (2001) Presynaptic role of cGMP-dependent protein kinase during long-lasting potentiation. J Neurosci 21: 143-149.
4. Beierwaltes WH (2002) Cyclooxygenase-2 products compensate for inhibition of nitric oxide regulation of renal perfusion. Am J Physiol Renal Physiol 283: F68-F72.
5. Bliss TV, and Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361: 31-39.
6. Bon CL, and Garthwaite J (2003) On the role of nitric oxide in hippocampal long-term potentiation. J Neurosci 23: 1941-1948.
7. Bredt DS (1999) Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 31: 577-596.
8. Bredt DS, and Snyder SH (1989) Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci U S A 86: 9030-9033.
9. Chen C, and Bazan NG (2005) Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J Neurophysiol 93: 929-941.
10. Chen C, Magee JC, and Bazan NG (2002) Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity. J Neurophysiol 87: 2851-2857.
11. Choi SH, Aid S, and Bosetti F (2009) The distinct roles of cyclooxygenase-1 and -2 in neuroinflammation: implications for translational research. Trends Pharmacol Sci 30: 174-181.
12. Davel L, D'Agostino A, Espanol A, Jasnis MA, Lauria de Cidre L, de Lustig ES, and Sales ME (2002) Nitric oxide synthase-cyclooxygenase interactions are involved in tumor cell angiogenesis and migration. J Biol Regul Homeost Agents 16: 181-189.
13. Dhir A, and Kulkarni SK (2006) Rofecoxib, a selective cyclooxygenase- 2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice. Inflammopharmacology 14: 222-225.
14. Dhir A, Naidu PS, and Kulkarni SK (2006) Effect of cyclooxygenase inhibitors on pentylenetetrazol (PTZ)- induced convulsions: Possible mechanism of action. Prog Neuropsychopharmacol Biol Psychiatry 30: 1478-1485.
15. Dudhgaonkar SP, Tandan SK, Kumar D, Naik AK, and Raviprakash V (2007) Ameliorative effect of combined administration of inducible nitric oxide synthase inhibitor with cyclooxygenase-2 inhibitors in neuropathic pain in rats. Eur J Pain 11: 528-534.
16. Feil R, and Kleppisch T (2008) NO/cGMP-dependent modulation of synaptic transmission. Handb Exp Pharmacol 184: 529-560.
17. Garthwaite J, Charles SL, and Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388.
18. Gholipour T, Jabbarzadeh A, Riazi K, Rasouli A, Nezami BG, Sharifzadeh M, and Dehpour AR (2008) Role of nitric oxide in the anticonvulsive effect of progesterone. Epilepsy Behav 13: 579-584.
19. Hewett SJ, Uliasz TF, Vidwans AS, and Hewett JA (2000) Cyclooxygenase-2 contributes to N-methyl-D-aspartatemediated neuronal cell death in primary cortical cell culture. J Pharmacol Exp Ther 293: 417-425.
20. Hoffman M (1991) A new role for gases: neurotransmission. Science 252: 1788.
21. Homayoun H, Khavandgar S, and Dehpour AR (2002) Anticonvulsant effects of cyclosporin A on pentylenetetrazole- induced seizure and kindling: modulation by nitricoxidergic system. Brain Res 939: 1-10.
22. Hughes FJ, Buttery LD, Hukkanen MV, O'Donnell A, Maclouf J, and Polak JM (1999) Cytokine-induced prostaglandin E2 synthesis and cyclooxygenase-2 activity are regulated both by a nitric oxide-dependent and -independent mechanism in rat osteoblasts in vitro. J Biol Chem 274: 1776-1782.
23. Itoh K, Watanabe M, Yoshikawa K, Kanaho Y, Berliner LJ, and Fujii H (2004) Magnetic resonance and biochemical studies during pentylenetetrazole-kindling development: the relationship between nitric oxide, neuronal nitric oxide synthase and seizures. Neuroscience 129: 757-766.
24. Kelley KA, Ho L, Winger D, Freire-Moar J, Borelli CB, Aisen PS, and Pasinetti GM (1999) Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am J Pathol 155: 995-1004
25. Kim HJ, Chung JI, Lee SH, Jung YS, Moon CH, and Baik EJ (2008) Involvement of endogenous prostaglandin F2alpha on kainic acid-induced seizure activity through FP receptor: the mechanism of proconvulsant effects of COX-2 inhibitors. Brain Res 1193: 153-161.
26. Kim SF, Huri DA, and Snyder SH (2005) Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 310: 1966-1970.
27. Lazarewicz JW, Salinska E, Stafiej A, Ziembowicz A, and Zieminska E (2000) NMDA receptors and nitric oxide regulate prostaglandin D2 synthesis in the rabbit hippocampus in vivo. Acta Neurobiol Exp (Wars) 60: 427-435.
28. Loscher W, and Schmidt D (1988) Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res 2: 145-181.
29. Luszczki JJ, Szadkowski M, and Czuczwar SJ (2007) Effect of NG-nitro-L-arginine on the anticonvulsant action of four second-generation antiepileptic drugs in pentetrazole- induced clonic seizures in mice. Pharmacol Rep 59: 467-473.
30. Mebazaa A, De Keulenaer GW, Paqueron X, Andries LJ, Ratajczak P, Lanone S, Frelin C, Longrois D, Payen D, Brutsaert DL, and Sys SU (2001) Activation of cardiac endothelium as a compensatory component in endotoxininduced cardiomyopathy: role of endothelin, prostaglandins, and nitric oxide. Circulation 104: 3137-3144.
31. Mollace V, Muscoli C, Masini E, Cuzzocrea S, and Salvemini D (2005) Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev 57: 217-252.
32. Moncada S, Palmer RM, and Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142.
33. Nidhi G, Balakrishnan S, and Pandhi P (1999) Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats. Methods Find Exp Clin Pharmacol 21: 609-612.
34. Noh HS, Kim DW, Cho GJ, Choi WS, and Kang SS (2006) Increased nitric oxide caused by the ketogenic diet reduces the onset time of kainic acid-induced seizures in ICR mice. Brain Res 1075: 193-200.
35. Oliveira MS, Furian AF, Royes LF, Fighera MR, Fiorenza NG, Castelli M, Machado P, Bohrer D, Veiga M, Ferreira J, Cavalheiro EA, and Mello CF (2008) Cyclooxygenase-2/ PGE2 pathway facilitates pentylenetetrazol-induced seizures. Epilepsy Res 79: 14-21.
36. Reid IC, and Stewart CA (1997) Seizures, memory and synaptic plasticity. Seizure 6: 351-359.
37. Riazi K, Roshanpour M, Rafiei-Tabatabaei N, Homayoun H, Ebrahimi F, and Dehpour AR (2006) The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway. Br J Pharmacol 147: 935-943.
38. Salvemini D (1997) Regulation of cyclooxygenase enzymes by nitric oxide. Cell Mol Life Sci 53: 576-582.
39. Salvemini D, Manning PT, Zweifel BS, Seibert K, Connor J, Currie MG, Needleman P, and Masferrer JL (1995) Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. J Clin Invest 96: 301-308.
40. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, and Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci U S A 90: 7240-7244.
41. Simmons DL, Botting RM, and Hla T (2004) Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56: 387-437.
42. Strauss KI, and Marini AM (2002) Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate- mediated cell death. J Neurotrauma 19: 627-38.
43. Tayal V, Kalra BS, and Chawla S (2008) Effect of celecoxib on anticonvulsant activity of carbamazepine against maximal electroshock-induced convulsions in mice. Methods Find Exp Clin Pharmacol 30: 727-730.
44. Toscano CD, Kingsley PJ, Marnett LJ, and Bosetti F (2008) NMDA-induced seizure intensity is enhanced in COX-2 deficient mice. Neurotoxicology 29: 1114-1120.
45. Tutka P, Barczynski B, and Wielosz M (2004) Convulsant and anticonvulsant effects of bupropion in mice. Eur J Pharmacol 499: 117-120.
46. Uzum G, Akgun-Dar K, Bahcekapili N, Diler AS, and Ziylan YZ (2005) Nitric oxide involvement in seizures elicited by pentylentetrazol and sex dependence. Int J Neurosci 115: 1503-1514.
47. Vane JR, Bakhle YS, and Botting RM (1998) Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120.
48. Wesolowska A, Nikiforuk A, and Chojnacka-Wojcik E (2006) Anticonvulsant effect of the selective 5-HT1B receptor agonist CP 94253 in mice. Eur J Pharmacol 541: 57-63.
49. Wojtal K, Gniatkowska-Nowakowska A, and Czuczwar SJ (2003) Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs? Pol J Pharmacol 55: 535-542.
50. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, and Worley PF (1993) Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386.
51. Yang H, and Chen C (2008) Cyclooxygenase-2 in synaptic signaling. Curr Pharm Des 14: 1443-1451.
52. Zhou L, and Zhu DY (2009) Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide 20: 223-230.